Navigation Links
Outcomes for cardiac valve procedure patients are affected by insurance status
Date:7/6/2011

CHICAGO (July 6, 2011) The type of primary insurance patients carry affects outcomes of cardiac valve operations in the United States according to a study in the May issue of the Journal of the American College of Surgeons. As a result, the type of primary insurance should be considered as an independent risk factor during preoperative risk stratification and planning, the researchers reported. They found that uninsured and Medicaid patients incur worse unadjusted and risk-adjusted outcomes following cardiac valve operations compared with those who carry private insurance.

In addition, the researchers found that uninsured and Medicaid payer status independently increases the risk of adjusted in-hospital mortality and the likelihood of postoperative complications even after accounting for socioeconomic status, hospital-related factors and several measures of co-morbid disease that are frequently encountered in low-income patient groups. In addition, Medicaid patients accrued the longest average hospital stay and highest total costs.

"The study findings indicate that primary payer status should be considered as an independent risk factor during preoperative patient risk evaluation," said the study's lead author, Damien J. LaPar, MD, with the University of Virginia Health System. "Our study findings highlight complex socioeconomic and health system-related factors that could be targeted to improve patient outcomes after cardiac valve operations."

From 2007 to 2008, the number of uninsured Americans rose by 600,000. Patients covered by government assistance insurance programs (ie, Medicaid and Medicare) increased by 4.4 million and the number of Americans covered by private insurance decreased by one million.

Previous research findings have shown that Medicaid and uninsured patients have worse outcomes than privately insured patients after medical admissions. However, while there have been studies on insurance status as a predictor of disease and the differences in allocation of surgical treatment as a function of payer status, no study has fully examined the impact of primary payer status among patients undergoing cardiac valve procedures, nor have they been evaluated in a national database.

The study evaluated 477,932 patients undergoing cardiac valve operations over a six-year period using discharge data from the Nationwide Inpatient Sample database. Patients in each payer group had different demographics; income and risk factors, and risk adjustment identified the independent effect of payer status.

After adjusting for risk factors, payer status remained a highly significant predictor of mortality. Specifically, uninsured, Medicaid, and Medicare status showed a 100 percent, 70 percent, and 36 percent increase in the odds of in-hospital death, respectively, compared with private insurance. A review of multiple variables for postoperative complications identified uninsured, Medicaid and Medicare payer status as important independent predictors of morbidity as well.


'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Related biology news :

1. Giving up smoking averts the adverse birth outcomes associated with tobacco
2. Study reveals that financial conflicts of interest are associated with positive study outcomes
3. Targeted adalimumab treatment can optimize long-term outcomes for patients with early RA
4. Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest
5. Physical health scores predict breast cancer outcomes
6. Some outcomes of the evolutionary race buck conventional wisdom
7. Researchers identify biomarkers of poor outcomes in preemies
8. Unique needs and outcomes of pregnant women with breast cancer identified
9. New cochlear implant could improve outcomes for patients
10. Smoking during radiation therapy for head and neck cancers linked to poorer outcomes
11. Disparities persist in outcomes for African-American women with advanced breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... April 27, 2016 , ... The Board of ... appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from ... founding commercial leaders responsible for the commercialization of multiple orphan drug indications. ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, Ph.D. ... Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology from the ... the suppression of graft vs. host disease (GVHD) under UM Professor Robert Levy Ph.D. ...
(Date:4/26/2016)... ... April 27, 2016 , ... ... Roca Rothgerber Christie LLP as an associate in the firm’s Intellectual Property practice ... electrical, mechanical and electromechanical patent applications. He has an electrical engineering and computer ...
(Date:4/26/2016)... ... April 26, 2016 , ... Mr. Palmer created the RPO ... the first multi-million dollar, multi-year managed services contract in the U.S. intelligence community with ... our leadership team,” said John Younger, founder of Accolo. “We are growing and ...
Breaking Biology Technology: